(P612) Encouraging AID Adoption in Pediatric Patients with Newly Diagnosed T1D

This poster outlines a QI project that aims to encourage the adoption of automated insulin delivery (AID) systems for patients with newly diagnosed T1D. Current practice at a large pediatric endocrinology center requires a 6-month waiting period before initiating AID. Retroactive chart reviews identified patients started on AID systems in < 6 months and analyzed key outcomes. Outcomes include hemoglobin A1c (HgbA1c), time in range (TIR), and incidence of DKA. Providers and educators were also polled on their attitudes towards the adoption of AID systems in new-onset patients. Project data suggests the success of early AID therapy may depend on the type of AID and questions the popularity versus efficacy of available systems for this population.